Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -1168.44% is 1302% below its 5-year average of -83.33%, near the low end of its 5-year range (-1168.44%–-38.17%).
1365.05% below its 12-month average of -79.75%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-03-31): -143.83%.
RETURN ON EQUITY (ROE)
-1168.44%
RETURN ON EQUITY (ROE) AVG TTM
-79.75%
RETURN ON EQUITY (ROE) AVG 3Y
-64.37%
RETURN ON EQUITY (ROE) AVG 5Y
-83.33%
RETURN ON EQUITY (ROE) AVG 10Y
-86.39%
RETURN ON EQUITY (ROE) AVG 15Y
-106.74%
RETURN ON EQUITY (ROE) AVG 20Y
-106.74%
CURRENT VS TTM AVG
-1365.05%
CURRENT VS 3Y AVG
-1715.21%
CURRENT VS 5Y AVG
-1302.18%
CURRENT VS 10Y AVG
-1252.47%
CURRENT VS 15Y AVG
-994.66%
CURRENT VS 20Y AVG
-994.66%
SECTOR MEDIAN · HEALTHCARE
-38.55%
median of 491 covered companies
CURRENT VS SECTOR MEDIAN
-2930.97%
vs the sector median at left
InMed Pharmaceuticals Inc.
Market Cap
$7.37M
Return on Equity (ROE)
-1168.44%
TTM Avg
-79.75%
3Y Avg
-64.37%
5Y Avg
-83.33%
Market Cap
$7.34M
Return on Equity (ROE)
N/A
TTM Avg
-2138.11%
3Y Avg
-1780.63%
5Y Avg
-1152.40%
Market Cap
$7.46M
Return on Equity (ROE)
-225.67%
TTM Avg
-236.53%
3Y Avg
-220.64%
5Y Avg
-186.37%
Market Cap
$7.17M
Return on Equity (ROE)
-218.65%
TTM Avg
-54.74%
3Y Avg
-35.36%
5Y Avg
-35.36%
Market Cap
$7.10M
Return on Equity (ROE)
-111.46%
TTM Avg
-348.97%
3Y Avg
-374.13%
5Y Avg
-408.25%
Market Cap
$7.09M
Return on Equity (ROE)
-120.58%
TTM Avg
-99.12%
3Y Avg
-428.18%
5Y Avg
-321.37%
Market Cap
$7.07M
Return on Equity (ROE)
-370.16%
TTM Avg
-148.31%
3Y Avg
-87.53%
5Y Avg
-43.20%
Market Cap
$7.83M
Return on Equity (ROE)
-91.75%
TTM Avg
-295.51%
3Y Avg
-88.38%
5Y Avg
-106.70%
Market Cap
$6.82M
Return on Equity (ROE)
-227.37%
TTM Avg
-118.13%
3Y Avg
-87.25%
5Y Avg
-55.09%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $7.37M | -1168.44% | -79.75% | -64.37% | -83.33% |
| HeartSciences Inc. (HSCS)vs › | $7.34M | N/A | -2138.11% | -1780.63% | -1152.40% |
| Longeveron Inc. (LGVN)vs › | $7.46M | -225.67% | -236.53% | -220.64% | -186.37% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.17M | -218.65% | -54.74% | -35.36% | -35.36% |
| KALA BIO, Inc. (KALA)vs › | $7.10M | -111.46% | -348.97% | -374.13% | -408.25% |
| Mangoceuticals, Inc. (MGRX)vs › | $7.09M | -120.58% | -99.12% | -428.18% | -321.37% |
| Co-Diagnostics, Inc. (CODX)vs › | $7.07M | -370.16% | -148.31% | -87.53% | -43.20% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.83M | -91.75% | -295.51% | -88.38% | -106.70% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.82M | -227.37% | -118.13% | -87.25% | -55.09% |
| GT Biopharma, Inc. (GTBP)vs › | $7.94M | -618.74% | 149.09% | 4.64% | -24.92% |
ROE
-1168.4%
ROA
-414.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-03-31 | -143.83% |
| 2025-12-31 | -68.90% |
| 2025-09-30 | -54.80% |
| 2025-06-30 | -48.13% |
| 2025-03-31 | -83.12% |
| 2024-12-31 | -89.01% |
| 2024-09-30 | -59.83% |
| 2024-06-30 | -60.96% |
| 2024-03-31 | -41.05% |
| 2023-12-31 | -38.17% |
| 2023-09-30 | -60.35% |
| 2023-06-30 | -63.31% |
| 2023-03-31 | -104.81% |
| 2022-12-31 | -98.84% |
| 2022-09-30 | -143.21% |
| 2022-06-30 | -168.81% |
| 2022-03-31 | -111.17% |
| 2021-12-31 | -81.68% |
| 2021-09-30 | -60.04% |
| 2021-06-30 | -107.52% |
| 2021-03-31 | -62.42% |
| 2020-12-31 | -66.95% |
| 2020-09-30 | -183.04% |
| 2020-06-30 | -163.77% |
| 2020-03-31 | -166.62% |
| 2019-12-31 | -120.40% |
| 2019-09-30 | -94.49% |
| 2019-06-30 | -72.33% |
| 2019-03-31 | -55.83% |
| 2018-12-31 | -47.16% |
| 2018-09-30 | -36.51% |
| 2018-06-30 | -32.64% |
| 2018-03-31 | -51.89% |
| 2017-12-31 | -44.02% |
| 2017-09-30 | -74.16% |
| 2017-06-30 | -55.29% |
| 2017-03-31 | -76.11% |
| 2016-12-31 | -115.50% |
| 2016-09-30 | -162.69% |
| 2016-06-30 | -208.79% |
| 2016-03-31 | -516.26% |
| 2015-12-31 | -535.38% |
| 2015-09-30 | -403.60% |
| 2015-06-30 | -286.51% |
| 2015-03-31 | -409.83% |
| 2014-12-31 | -255.90% |
| 2014-09-30 | -141.17% |
| 2014-06-30 | -75.77% |
| 2012-03-31 | -92.39% |
| 2011-12-31 | -246.34% |
| 2011-09-30 | -222.34% |
| 2011-06-30 | -155.71% |
| 2011-03-31 | -176.00% |
| 2004-04-30 | -534.49% |
| 2003-10-31 | -761.98% |
| 2003-07-31 | -468.77% |
